![]() ![]() ![]() In total, 1,966 articles were assessed for eligibility, yielding 246 articles describing 663 neonates. Therefore, this scoping review was conducted on the first 2 years of the pandemic and included mothers with reverse transcription-polymerase chain reaction confirmed COVID-19 and their resulting positive or negative neonates. Although health systems adopted protocols that addressed pregnant women and their neonates during the pandemic, limited research has assessed the validity of Apgar scores for determining neonatal conditions in the context of COVID-19. The use of the Apgar score-a discrete numerical index used to evaluate neonatal condition immediately following delivery that has been used ubiquitously as a clinical indicator of neonatal condition and widely reported in the literature for decades-has continued during the pandemic. The coronavirus disease 2019 (COVID-19) pandemic has had profound impacts on healthcare systems worldwide, particularly regarding the care of pregnant women and their neonates. 3Biomedical and Mobile Health Technology Laboratory, Department of Health Sciences and Technology, Zurich, Switzerland.2Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States. ![]() 1Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.Melissa Chao 1,2, Carlo Menon 3 and Mohamed Elgendi 3 * ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |